Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-16 Sale | 2026-06-18 4:08 pm | 10x Genomics Inc. | TXG | SULIMAN SHEHNAAZ Director | 5,723 | $32.63 | $186,756 | 31,722 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 6:41 pm | Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director | 5,740 | $25.12 | $144,189 | 42,009 (Direct) | View |
| 2021-12-10 Sale | 2021-12-14 8:23 pm | Alector Inc. | ALEC | SULIMAN SHEHNAAZ President and COO | 150,000 | $21.5 | $3,225,316 | 787,972 (Direct) | View |
| 2021-12-08 Sale | 2021-12-10 7:20 pm | Alector Inc. | ALEC | SULIMAN SHEHNAAZ President and COO | 150,000 | $22.81 | $3,421,159 | 1,221,998 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-04 Option Award | 2026-06-08 7:26 pm | N/A N/A | 10x Genomics Inc. | TXG | SULIMAN SHEHNAAZ Director | 8,829 | $0 | 37,445 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 6:41 pm | N/A 2036-05-14 | Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director | 21,809 | $0 | 42,009 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 5:22 pm | N/A N/A | 10x Genomics Inc. | TXG | SULIMAN SHEHNAAZ Director | 15,357 | $0 | 28,616 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 6:34 pm | N/A 2035-05-15 | Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director | 16,527 | $0 | 36,727 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 2:22 pm | N/A 2034-06-18 | Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director | 15,245 | $0 | 30,100 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 4:23 pm | N/A N/A | 10x Genomics Inc. | TXG | SULIMAN SHEHNAAZ Director | 8,649 | $0 | 13,259 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:43 pm | N/A 2033-06-14 | 10x Genomics Inc. | TXG | SULIMAN SHEHNAAZ Director | 6,526 | $0 | 9,271 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 2:30 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director | 10,970 | $0 | 21,965 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 1:48 pm | N/A 2032-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director | 9,545 | $0 | 17,240 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:16 pm | N/A 2032-06-15 | 10x Genomics Inc. | TXG | SULIMAN SHEHNAAZ Director | 7,420 | $0 | 8,045 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-14 8:23 pm | N/A N/A | Alector Inc. | ALEC | SULIMAN SHEHNAAZ President and COO | 150,000 | $17.23 | 787,972 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-14 8:23 pm | N/A 2029-12-31 | Alector Inc. | ALEC | SULIMAN SHEHNAAZ President and COO | 150,000 | $0 | 787,972 (Direct) | View |
| 2021-12-08 Exercise | 2021-12-10 7:20 pm | N/A N/A | Alector Inc. | ALEC | SULIMAN SHEHNAAZ President and COO | 55,187 | $10.24 | 1,221,998 (Direct) | View |
| 2021-12-08 Exercise | 2021-12-10 7:20 pm | N/A N/A | Alector Inc. | ALEC | SULIMAN SHEHNAAZ President and COO | 94,813 | $17.23 | 1,221,998 (Direct) | View |
| 2021-12-08 Exercise | 2021-12-10 7:20 pm | N/A 2029-12-31 | Alector Inc. | ALEC | SULIMAN SHEHNAAZ President and COO | 150,000 | $0 | 1,221,998 (Direct) | View |